What is the official website of Boston Scientific Deep Brain Stimulation ?

The official website of Boston Scientific Deep Brain Stimulation is https://www.bostonscientific.com/dbs.

What is Boston Scientific Deep Brain Stimulation's cybersecurity risk score?

Boston Scientific Deep Brain Stimulation has an AI-generated cybersecurity risk score of 764 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Boston Scientific Deep Brain Stimulation experienced?

According to Rankiteo, Boston Scientific Deep Brain Stimulation currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Boston Scientific Deep Brain Stimulation been affected by any supply chain cyber incidents ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation has been affected by a supply chain cyber incident involving Disc Soft ltd, with the incident ID DIS1777998353.

Does Boston Scientific Deep Brain Stimulation have SOC 2 Type 1 certification ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation is not certified under SOC 2 Type 1.

Does Boston Scientific Deep Brain Stimulation have SOC 2 Type 2 certification ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation does not hold a SOC 2 Type 2 certification.

Does Boston Scientific Deep Brain Stimulation comply with GDPR ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation is not listed as GDPR compliant.

Does Boston Scientific Deep Brain Stimulation have PCI DSS certification ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation does not currently maintain PCI DSS compliance.

Does Boston Scientific Deep Brain Stimulation comply with HIPAA ?

According to Rankiteo, Boston Scientific Deep Brain Stimulation is not compliant with HIPAA regulations.

Does Boston Scientific Deep Brain Stimulation have ISO 27001 certification ?

According to Rankiteo,Boston Scientific Deep Brain Stimulation is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Boston Scientific Deep Brain Stimulation operate in ?

Boston Scientific Deep Brain Stimulation operates primarily in the Medical Equipment Manufacturing industry.

How many employees does Boston Scientific Deep Brain Stimulation have ?

Boston Scientific Deep Brain Stimulation employs approximately None employees people worldwide.

Does Boston Scientific Deep Brain Stimulation own any subsidiaries ?

Boston Scientific Deep Brain Stimulation presently has no subsidiaries across any sectors.

How many LinkedIn followers does Boston Scientific Deep Brain Stimulation have ?

Boston Scientific Deep Brain Stimulation's official LinkedIn profile has approximately 14,474 followers.

What is the NAICS classification code for Boston Scientific Deep Brain Stimulation ?

Boston Scientific Deep Brain Stimulation is classified under the NAICS code 3391, which corresponds to Medical Equipment and Supplies Manufacturing.

Does Boston Scientific Deep Brain Stimulation have a Crunchbase profile ?

No, Boston Scientific Deep Brain Stimulation does not have a profile on Crunchbase.

Does Boston Scientific Deep Brain Stimulation have a LinkedIn profile ?

Yes, Boston Scientific Deep Brain Stimulation maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/boston-scientific-dbs.

How many cybersecurity incidents has Boston Scientific Deep Brain Stimulation experienced ?

As of June 15, 2026, Rankiteo reports that Boston Scientific Deep Brain Stimulation has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Boston Scientific Deep Brain Stimulation have ?

Boston Scientific Deep Brain Stimulation has an estimated 5,840 peer or competitor companies worldwide.

What types of cybersecurity incidents has Boston Scientific Deep Brain Stimulation faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BSDBS

Boost Score +25 with badge (5 left)

764

/1000

Fair

789

/1000

Fair

Boston Scientific Deep Brain Stimulation Vendor Cyber Rating & Cyber Score

bostonscientific.com

Add Your Compliance Badge

Boston Scientific is a global leader in Deep Brain Stimulation. Innovative thinking. State-of-the-art technology. An unyielding commitment to quality in everything we do. At Boston Scientific, we're committed to meaningful innovation for Deep Brain Stimulation, to empower health care providers, and to improve the lives of patients worldwide. This channel shares content for physicians around the world.

BSDBS A.I CyberSecurity Scoring

Scoring History

BSDBS

Boston Scientific Deep Brain Stimulation CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Boston Scientific

Cyber Attack

100

5/2026

Disc Soft ltd

DIS1777998353

Boston Scientific D...

Ransomware

100

5/2023

BOS559525511042...

Loading…

A.I.

BSDBS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BSDBS

Incidents vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.

Incident Types BSDBS vs Medical Equipment Manufacturing Industry Avg (This Year)

No incidents recorded for Boston Scientific Deep Brain Stimulation in 2026.

Incident History - BSDBS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Boston Scientific Deep Brain Stimulation Subsidiaries

BSDBS

Medical Equipment Manufacturing

Website: https://www.bostonscientific.com/dbs

Company Size: None employees

Boston ScientificMedical Equipment Manufacturing

Boston Scientific CardiologyMedical Equipment Manufacturing

Boston Scientific EndoscopyMedical Equipment Manufacturing

Boston Scientific Peripheral InterventionsMedical Equipment Manufacturing

Boston Scientific LATAMMedical Equipment Manufacturing

Loading…

Boston Scientific Deep Brain Stimulation Similar Companies

Medline

medline.com

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Edwards Lifesciences

edwards.com

Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.

Henry Schein

cb henryschein.com

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.

Zimmer Biomet

zimmerbiomet.com

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025

Baxter International Inc.

baxter.com

For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.

Smith+Nephew

smith-nephew.com

Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.

Alcon

alcon.com

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Stryker

stryker.com

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

BD

cb bd.com

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

Loading…

NEWS

Boston Scientific Deep Brain Stimulation CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

July 20, 2025 07:00 AM

Boston Scientific’s AI Strategy: Analysis of Dominance in Medical Technology

Boston Scientific's AI strategy set to dominate medical technology—integrating smart devices, talent, and data into unbeatable clinical...

Read Article

July 15, 2024 07:00 AM

MedTech Giants Drive Innovation and Growth: Key Developments and Achievements

Medtronic, Johnson & Johnson, Siemens Healthineers, GE HealthCare, Abbott, Stryker, BD, Philips, Boston Scientific, and Zimmer Biomet...

Read Article

June 26, 2024 07:00 AM

Boston Scientific’s DBS software gains CE as Parkinson’s treatments advance

Boston Scientific has achieved a significant milestone with the European CE [Conformité Européenne] marking of its Vercise Neural Navigator 5 software.

Read Article

March 07, 2024 08:00 AM

Brain-Computer Interfaces Go Beyond The Hype Of Neuralink

The impact Elon Musk is singlehandedly having on the field of neurotechnology and brain computer interfaces through Neuralink is both undeniable and important.

Read Article

November 20, 2023 08:00 AM

Boston Scientific acquires Relievant Medsystems for $850m

Boston Scientific has concluded the acquisition of Relievant Medsystems for an upfront cash payment of $850m.

Read Article

August 31, 2023 07:00 AM

FDA approving more Deep Brain Stimulation and Transcranial Magnetic Stimulation devices

FDA has cleared Deep Brain Stimulation (DBS) and Transcranial Magnetic Stimulation (TMS) devices with updated functionality and expanded...

Read Article

July 12, 2023 07:00 AM

FDA approves Boston Scientific’s Vercise Neural Navigator 5 Software

The US FDA has granted approval for Boston Scientific's Vercise Neural Navigator 5 Software for deep brain stimulation (DBS).

Read Article

July 28, 2022 07:00 AM

Vercise Gevia Deep Brain Stimulation (DBS) System, US

Vercise™ Gevia™ deep brain stimulation (DBS) system is a directional neurostimulation device developed by Boston Scientific.

Read Article

February 19, 2021 08:00 AM

First US surgery carried out with next-gen deep brain stimulation tech

Boston Scientific's fourth-generation Vercise Genus deep brain stimulation system has been implanted in its first ever US surgery.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-12191

SUMMARY

A vulnerability was found in Comma AI Openpilot 0.11. This issue affects the function pickle.load/pickle.loads of the file selfdrive/modeld/modeld.py of the component Pickle Module. The manipulation results in deserialization. The attack is only possible with local access. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-14

Updated

Date2026-06-14

RISK INFORMATION (Score: 7.8)

cvss2

Base Score: 6.8

Complexity: LOW

AV:L/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-12190

SUMMARY

A vulnerability has been found in Genspark AI Workspace App 2.8.4 on Android. This vulnerability affects unknown code of the component ai.mainfunc.genspark. The manipulation leads to improper authorization in handler for custom url scheme. The attack can only be performed from a local environment. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-14

Updated

Date2026-06-14

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-12189

SUMMARY

A flaw has been found in Moovit Bus & Public Transit App 1.18 on Android. This affects an unknown part of the component com.tranzmate. Executing a manipulation can lead to improper authorization in handler for custom url scheme. The attack can only be executed locally. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-14

Updated

Date2026-06-14

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-12188

SUMMARY

A vulnerability was detected in Grit42 Grit up to 0.11.0. Affected by this issue is some unknown functionality of the file modules/core/backend/app/controllers/concerns/grit/core/grit_entity_controller.rb of the component GritEntityController. Performing a manipulation results in sql injection. The attack may be initiated remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-06-14

Updated

Date2026-06-14

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-12187

SUMMARY

A security vulnerability has been detected in GL.iNet GL-MT3000 up to 4.4.5. Affected by this vulnerability is an unknown functionality of the file /usr/bin/one_click_upgrade of the component Online Firmware Upgrade Handler. Such manipulation leads to command injection. The attack can be launched remotely. The exploit has been disclosed publicly and may be used. Upgrading to version 4.7 addresses this issue. Upgrading the affected component is advised. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.

Published

Date2026-06-14

Updated

Date2026-06-14

RISK INFORMATION (Score: 8.8)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 7.4

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…